EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Contribution of Prostaglandin E2‐Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood–Brain Barrier Crossing Celecoxib Derivative

Chih-Jie Shen, Hsien-Chung Chen, Chien-Liang Lin, Amandeep Thakur, Raphael Onuku, I-Chung Chen, Hao-Yi Li, Kwang-Yu Chang, Jian-Ying Chuang, Wen-Bin Yang, Hong-Yi Lin, Yi-Ru Shen und 3 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202506336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Chih-Jie Shen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Neuroscience, Taipei Medical University, Taipei, 11031, Taiwan. Hauptthemen laut MEDLINE: Glioblastoma, Celecoxib, Dinoprostone, Blood-Brain Barrier. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taipei Medical University, Chi Mei Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is a highly aggressive brain tumor. Its poor prognosis is primarily due to recurrence and resistance to standard therapies, such as temozolomide (TMZ). Emerging evidence suggests that neuronal excitation within the tumor microenvironment contributes to the progression and chemoresistance of GBM. This study identifies prostaglandin E2 (PGE2) as a key regulator of neuronal activity that promotes tumor resistance. It is demonstrated that PGE2 activates neurons via the prostaglandin E1 (EP1) receptor, leading to intracellular calcium influx and phosphorylation of calcium/calmodulin dependent protein kinase II (CaMKII), which enhances synaptic plasticity. Neuronal excitation results in upregulation of synaptic proteins and neurotransmitter alterations, notably increasing glutamine and asparagine levels, which correlate with heightened chemoresistance. Co‐culture experiments confirmed that PGE2‐stimulated neurons induce resistance in adjacent GBM cells, highlighting a neuron‐tumor interaction that facilitates recurrence. To overcome this resistance mechanism, compound 11 is developed, a novel blood‐brain barrier (BBB)‐permeable celecoxib derivative that effectively inhibits PGE2 signaling. Treatment with compound 11 significantly reduces GBM growth, impairs neuronal excitation, and improves survival outcomes in preclinical models. These findings underscore PGE2‐induced neuronal excitation as a critical driver of drug resistance in GBM, and implicate compound 11 as a promising therapeutic agent to counteract PGE2‐driven tumor recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaCelecoxibDinoprostoneBlood-Brain BarrierDrug Resistance, NeoplasmNeuronsBrain NeoplasmsAnimalsHumansMiceCell Line, TumorTemozolomide

Stichwörter der Autor:innen

CaMKIIEP1blood‐brain barrierglioblastomaneuronprostaglandin E2

Substanzen

CelecoxibDinoprostoneTemozolomide

Autor:innen und Institutionen

  • Research Center for Neuroscience, Taipei Medical University, Taipei, 11031, Taiwan.
  • Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei, 11031, Taiwan.
  • Taipei Neuroscience Institute, Taipei Medical University, Taipei, 11031, Taiwan.
  • Department of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, Taipei, 11031, Taiwan.
  • Chi Mei Medical Center, Tainan, 71004, Taiwan.
  • School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan.

ORCID-Profile: Tsung-I Hsu

Förderung

  • National Science and Technology Council
  • Taipei Medical University
  • Chi Mei Medical Center
  • Sunny Brain Tumor and Brain Disease Research and Development Fund

Zitieren

APA

Shen, C. J., Chen, H. C., Lin, C. L., Thakur, A., Onuku, R., Chen, I. C., Li, H. Y., Chang, K. Y., Chuang, J. Y., Yang, W. B., Lin, H. Y., Shen, Y. R., Liou, J. P., Chang, W. C., & Hsu, T. I. (2025). Contribution of Prostaglandin E2‐Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood–Brain Barrier Crossing Celecoxib Derivative. Advanced Science. https://doi.org/10.1002/advs.202506336

Vancouver

Shen CJ, Chen HC, Lin CL, Thakur A, Onuku R, Chen IC, et al. Contribution of Prostaglandin E2‐Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood–Brain Barrier Crossing Celecoxib Derivative. Advanced Science. 2025. doi:10.1002/advs.202506336

BibTeX
@article{Shen2025,
  author = {Shen, Chih-Jie and Chen, Hsien-Chung and Lin, Chien-Liang and Thakur, Amandeep and Onuku, Raphael and Chen, I-Chung and Li, Hao-Yi and Chang, Kwang-Yu and Chuang, Jian-Ying and Yang, Wen-Bin and Lin, Hong-Yi and Shen, Yi-Ru and Liou, Jing-Ping and Chang, Wen-Chang and Hsu, Tsung-I},
  title = {Contribution of Prostaglandin E2‐Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood–Brain Barrier Crossing Celecoxib Derivative},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202506336}
}
Kostenlos starten →